Drug-eluting stent in malignant biliary obstruction

Dong Ki Lee, Sung Ill Jang

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

Endoscopic stent insertion is the treatment of choice for patients with malignant biliary obstruction. However, conventional stents enable only mechanical palliation of the obstruction, without any anti-tumor effects. Drugeluting stent (DES), which was first introduced in coronary artery disease, are currently under investigation for sustaining stent patency and prolonging patient survival by inhibiting tumor ingrowth in malignant biliary obstruction. Many factors affecting efficient drug delivery have been studied to determine how drugs with antitumor effects suppress tumor ingrowth, including the specific drugs incorporated, means of incorporating the drugs, mode of drug release, and stent structure. Advances have resulted in the construction of more effective non-vascular DES and ongoing clinical research. Non-vascular DES is expected to play a vital role in prolonging the survival of patients with malignant biliary obstruction.

Original languageEnglish
Title of host publicationNanosystems in Engineering and Medicine
Volume8548
DOIs
Publication statusPublished - 2012 Dec 1
EventNanosystems in Engineering and Medicine - Incheon, Korea, Republic of
Duration: 2012 Sep 102012 Sep 12

Other

OtherNanosystems in Engineering and Medicine
CountryKorea, Republic of
CityIncheon
Period12/9/1012/9/12

Fingerprint

Drug-Eluting Stents
Stents
drugs
Pharmaceutical Preparations
tumors
Tumors
coronary artery disease
sustaining
Neoplasms
insertion
Survival
delivery
Drug delivery
Antineoplastic Agents
Coronary Artery Disease
Research

All Science Journal Classification (ASJC) codes

  • Atomic and Molecular Physics, and Optics
  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Radiology Nuclear Medicine and imaging

Cite this

Lee, D. K., & Jang, S. I. (2012). Drug-eluting stent in malignant biliary obstruction. In Nanosystems in Engineering and Medicine (Vol. 8548). [85483P] https://doi.org/10.1117/12.2000469
Lee, Dong Ki ; Jang, Sung Ill. / Drug-eluting stent in malignant biliary obstruction. Nanosystems in Engineering and Medicine. Vol. 8548 2012.
@inproceedings{ce41cf395cc349008afaf0d91bdc3139,
title = "Drug-eluting stent in malignant biliary obstruction",
abstract = "Endoscopic stent insertion is the treatment of choice for patients with malignant biliary obstruction. However, conventional stents enable only mechanical palliation of the obstruction, without any anti-tumor effects. Drugeluting stent (DES), which was first introduced in coronary artery disease, are currently under investigation for sustaining stent patency and prolonging patient survival by inhibiting tumor ingrowth in malignant biliary obstruction. Many factors affecting efficient drug delivery have been studied to determine how drugs with antitumor effects suppress tumor ingrowth, including the specific drugs incorporated, means of incorporating the drugs, mode of drug release, and stent structure. Advances have resulted in the construction of more effective non-vascular DES and ongoing clinical research. Non-vascular DES is expected to play a vital role in prolonging the survival of patients with malignant biliary obstruction.",
author = "Lee, {Dong Ki} and Jang, {Sung Ill}",
year = "2012",
month = "12",
day = "1",
doi = "10.1117/12.2000469",
language = "English",
isbn = "9780819492920",
volume = "8548",
booktitle = "Nanosystems in Engineering and Medicine",

}

Lee, DK & Jang, SI 2012, Drug-eluting stent in malignant biliary obstruction. in Nanosystems in Engineering and Medicine. vol. 8548, 85483P, Nanosystems in Engineering and Medicine, Incheon, Korea, Republic of, 12/9/10. https://doi.org/10.1117/12.2000469

Drug-eluting stent in malignant biliary obstruction. / Lee, Dong Ki; Jang, Sung Ill.

Nanosystems in Engineering and Medicine. Vol. 8548 2012. 85483P.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

TY - GEN

T1 - Drug-eluting stent in malignant biliary obstruction

AU - Lee, Dong Ki

AU - Jang, Sung Ill

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Endoscopic stent insertion is the treatment of choice for patients with malignant biliary obstruction. However, conventional stents enable only mechanical palliation of the obstruction, without any anti-tumor effects. Drugeluting stent (DES), which was first introduced in coronary artery disease, are currently under investigation for sustaining stent patency and prolonging patient survival by inhibiting tumor ingrowth in malignant biliary obstruction. Many factors affecting efficient drug delivery have been studied to determine how drugs with antitumor effects suppress tumor ingrowth, including the specific drugs incorporated, means of incorporating the drugs, mode of drug release, and stent structure. Advances have resulted in the construction of more effective non-vascular DES and ongoing clinical research. Non-vascular DES is expected to play a vital role in prolonging the survival of patients with malignant biliary obstruction.

AB - Endoscopic stent insertion is the treatment of choice for patients with malignant biliary obstruction. However, conventional stents enable only mechanical palliation of the obstruction, without any anti-tumor effects. Drugeluting stent (DES), which was first introduced in coronary artery disease, are currently under investigation for sustaining stent patency and prolonging patient survival by inhibiting tumor ingrowth in malignant biliary obstruction. Many factors affecting efficient drug delivery have been studied to determine how drugs with antitumor effects suppress tumor ingrowth, including the specific drugs incorporated, means of incorporating the drugs, mode of drug release, and stent structure. Advances have resulted in the construction of more effective non-vascular DES and ongoing clinical research. Non-vascular DES is expected to play a vital role in prolonging the survival of patients with malignant biliary obstruction.

UR - http://www.scopus.com/inward/record.url?scp=84875725081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875725081&partnerID=8YFLogxK

U2 - 10.1117/12.2000469

DO - 10.1117/12.2000469

M3 - Conference contribution

SN - 9780819492920

VL - 8548

BT - Nanosystems in Engineering and Medicine

ER -

Lee DK, Jang SI. Drug-eluting stent in malignant biliary obstruction. In Nanosystems in Engineering and Medicine. Vol. 8548. 2012. 85483P https://doi.org/10.1117/12.2000469